Skip to main content
U.S. flag

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Find more clinical trials

Improvisational Movement for People with Memory Loss and Their Caregivers (IMOVE)

Start: February 6, 2018
End: May 2021
Enrollment: 240

What Is This Study About?

This study will test dance and social engagement as a method to decrease behavioral symptoms and improve quality of life in older adults with mild cognitive impairment (MCI) or early Alzheimer's disease. Participants in this study will attend one-hour improvisational dance lessons (group or non-group) or party game sessions two times a week for 12 weeks. Dance moves and games will be varied within the sessions to incorporate pacing and variability. Another group will be randomized as a no-contact control group and will continue their current disease management and lifestyle for 12 weeks. After the study, these participants may join a weekly community improvisational dance class for as many sessions as they would like.

Do I Qualify To Participate in This Study?

Minimum Age: 60 Years

Maximum Age: 85 Years

Must have:

  • MCI or early Alzheimer's or mixed dementia of Alzheimer's disease and vascular dementia
  • Speak English
  • Study partner who is a family member, spends approximately 10 hours a week with the person with MCI or early Alzheimer's, and is willing to be an active study partner
  • Not enrolled in another study in past six months

Must NOT have:

  • Other causes of dementia, such as early-onset Alzheimer's, frontotemporal, Lewy body, or Parkinsonian dementia
  • Untreated depression
  • Current cancer treatment or other major medical problems that might affect cognition or movement
  • Other neurological disorders, such as Parkinson's disease or multiple sclerosis
  • Taking medication that could affect safety during study
  • Planned extensive travel during the study period
  • Any reason the study doctor or personal physician would advise against participation

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Who Sponsors This Study?

Lead: Wake Forest University Health Sciences

Collaborator Sponsor

  • National Center for Complementary and Integrative Health (NCCIH)

Source: ClinicalTrials.gov ID: NCT03333837

alzheimers.gov

An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health